Cis-element decoys useful as anti-tumor therapeutics
OwnerXuegen Wang, Qing Ye +2inventors
InventorsXuegen Wang, Qing Ye, Wuling Chen, Ying Feng
Life of this patent
Estimating the term…
Abstract
An anti-cancer or oncogene switching therapeutics that employ sequence-specific nucleic acid decoys for competitive binding of transcription factors. These nucleic acid decoys can competitively bind to transcription factors regulating the expression of oncogenes including CREB, JUN/FOS, JUN/ATF and MYC/MAX in the cell, leading to the inhibition of tumor cell growth. As a result, they can be developed into anti-cancer therapeutic drugs.
Claims37
An isolated composition comprising a 15-45 oligonucleotide sequence having a double-stranded structure having affinity for binding a transcription factor in a host cell.
An isolated composition comprising a 15-45 oligonucleotide comprising a double-stranded sequence 5′-STGACGTMR-3′ which is capable of binding to transcription factor CREB.
An isolated composition comprising a 15-45 oligonucleotide comprising a double-stranded sequence 5′-STGASTMA-3′ which is capable of binding to transcription factor AP-1 (JUN/FOS).
An isolated composition comprising a 15-45 oligonucleotide comprising a double-stranded sequence 5′-TTACCTCA-3′ which is capable of binding to transcription factor JUN/ATF.
An isolated composition comprising a 15-45 oligonucleotide comprising a double-stranded sequence 5′-TCTCTTA-3′ which is capable of binding to transcription factor C-MYC.
An isolated composition comprising a 15-45 oligonucleotide comprising a double-stranded sequence 5′-RACCACGTGGTY-3′ which is capable of binding to transcription factor MYC/MAX.
An isolated composition comprising an element selected from a group consisting of (a) a polynucleotide selected from a group consisting of a 15-45 oligonucleotide comprising a double-stranded sequence 5′-STGACGTMR-3′ which is capable of binding to transcription factor CREB, a 15-45 oligonucleotide comprising a double-stranded sequence 5′-STGASTMA-3′ which is capable of binding to transcription factor AP-1 (JUN/FOS), a 15-45 oligonucleotide comprising a double-stranded sequence 5′-TTACCTCA-3′ which is capable of binding to transcription factor JUN/ATF, a 15-45 oligonucleotide comprising a double-stranded sequence 5′-TCTCTTA-3′ which is capable of binding to transcription factor C-MYC, and a 15-45 oligonucleotide comprising a double-stranded sequence 5′-RACCACGTGGTY-3′ which is capable of binding to transcription factor MYC/MAX;
- (b) a polynucleotide of at least 70% homology to the polynucleotide of (a);
- and (c) a combination thereof.
A method for regulating gene transcription and cell growth in a target cell comprising the steps of:
- a) providing one or more transcription regulatory element decoys each comprising a polynucleotide, wherein said polynucleotide is selected from a group consisting of SEQ ID NO:
- 1 to 30;
- and
- b) exposing said target cell to said polynucleotide under a condition that said polynucleotide alters gene transcription and cell growth.
Dependencies are inferred from the claim text.